In the rapidly evolving pharmaceutical industry, pharma companies seek innovative ways to maximize value across the entire product life cycle.
In this webinar, expert speakers from Optum Life Sciences offer a simple, yet effective approach to achieve this: determining the right questions to solve a complex challenge. They’ll discuss what questions they consider when exploring the potential of a therapy, what type of real-world data to use, the target population for a therapy and what evidence will resonate with stakeholders.
This approach may help create efficiencies in:
- Finding eligible patients and streamlining processes for clinical trials and post-launch
- Harnessing real-world evidence (RWE) and analytics for informed decision-making
- Applying data-driven strategies for patients and providers to help optimize disease treatment and advance outcomes
Register for this webinar to discover how pharma companies are leveraging this collaborative approach to simplify vendor management, streamline clinical trial operations and optimize treatment outcomes.
Speakers
Dr. Kevin Heath, MD, MPH, FACP, Chief Medical Officer, Optum Life Sciences
Dr. Kevin Heath is the Chief Medical Officer at Optum Life Sciences, where he leads clinical strategy and innovation. He focuses on improving patient outcomes through evidence-based practices and advanced data analytics.
Read more...
Dr. Heath has extensive experience in medicine and healthcare leadership. Before his current role, he was the Senior Medical Director at OptumCare Clinical Performance, leading initiatives to enhance diagnostic and documentation accuracy for complex medical conditions. He also worked in United Healthcare Payment Integrity and data and analytics product development and build in Dublin as part of Optum Ireland.
He is board-certified in nephrology and internal medicine and has practiced in both private nephrology and hospitalist settings. He holds a BS in Biology and Philosophy, an MS in Clinical Anatomy and an MD from Creighton University. He also has a Master of Healthcare Leadership from Brown University and an MPH in Epidemiology from Harvard University’s T.H. Chan School of Public Health.
His recent peer-reviewed publications are found in BMJ, Journal of Vascular Surgery, Medical Care and American Journal of Preventive Medicine Focus. Dr. Heath is a collaborator with The American Heart Association on peripheral vascular disease (PAD) and is a member of the working group on the AHA published PAD National Action Plan.
Read Less...
Olivia Banyon, MPH, Senior Vice President, Patient and Provider Solutions, Optum Life Sciences
Olivia Banyon leads the Cross-Optum clinical engagement team with 20+ years’ experience in the life sciences/pharmaceutical and healthcare industries. Most recently, Olivia was Senior Director of Innovative Solutions and Population Health at Sanofi. In this role, she led numerous pilot studies with large health systems, national and regional payers and provider groups. Olivia has also worked for Pfizer and Merck-Medco to lead quality improvement and complex disease management programs nationally.
Read more...
She has built new companies from start-up to mature phases in clinical decision-making while developing new products and solutions in the areas of adherence, disease management, predictive analytics, patient education and wellness and behavioral change science.
Read Less...
Lou Brooks Jr., MA, Senior Vice President, Real-World Data and Analytics, Optum Life Sciences
Lou Brooks leads a team of individuals responsible for the development and deployment of health care data solutions that enable organizations to fuel their real-world evidence generation activities to support the development and commercialization of health care products and services. Over the past 25 years, he has led a variety of real-world data analytics teams, all focused on developing a better understanding of customer behavior across several industries, including telecommunications, pharmaceutical products and consumer packaged goods.
Read more...
Lou has worked in the pharmaceutical industry since 1997. During his tenure at Optum, Lou has been focused on continuing to drive real-world-based data analytics projects using primarily claims and EMR data sources, as well as developing technology solutions that enable analytics to be packaged and executed in a more efficient and effective manner by a range of users. Lou has experience across a wide variety of therapeutic categories, including autoimmune disorders, diabetes, respiratory, CNS, oncology and cardiovascular conditions.
Read Less...
Stacey DaCosta Byfield, PhD, MPH, Vice President, Value and Evidence Solutions, Optum Life Sciences
As the Vice President of Value and Evidence Solutions, Dr. Stacey DaCosta Byfield oversees the researcher teams responsible for conducting observational research studies using administrative claims, EHR/medical record data and other secondary data sources, as well as studies utilizing primary data collection methodologies.
Read more...
Dr. DaCosta Byfield has been with HEOR since 2009 and previously led the HEOR Oncology and Immunology researcher teams where she provided oversight of opportunities and studies in these areas.
Prior to joining Optum, she worked in the Department of Drug Use Policy and Pharmacoeconomics at the University of Texas MD Anderson Cancer Center as a Pharmacoeconomics Research Specialist. In this capacity, her main responsibilities included developing research designs to evaluate clinical, economic and humanistic outcomes of pharmaceutical products and services. She holds a PhD in Tumor Biology from Georgetown University and completed a basic science fellowship at the National Cancer Institute where her work focused on identifying targets of pharmaceutical intervention for metastatic breast cancer.
Dr. DaCosta Byfield also received her MPH with a concentration in clinical effectiveness from the Harvard T. H. Chan School of Public Health and has completed the Program in Cancer Outcomes Research Training (PCORT) Fellowship, a jointly sponsored program by the Massachusetts General Hospital and the Dana-Farber Harvard Cancer Center in Boston, Massachusetts.
Dr. DaCosta Byfield has been an author or co-author in numerous peer-reviewed journals, including Journal of Oncology Practice, Journal of Managed Care Specialty Pharmacy, American Journal of Clinical Oncology, American Journal of Gastroenterology, Archives of Dermatology Research, BJU International, Journal of Cancer Therapy, Journal of Cell Science, Journal of Neuro Oncology, Cancer Research, Melanoma Research and Molecular Pharmacology.
Read Less...
Tracy Ohrt, MS, BS, PMP, CCRA, CCRC, Director, Clinical Operations, Clinical Trial Solutions, Optum Life Sciences
Ms. Tracy Ohrt provides oversight and management of clinical operations, including all research projects within the CTS. Tracy works closely with the life science customers supporting study feasibility and site identification and acts as a liaison with the site staff from the healthcare organizations and vendors. She partners with the clinical data and analytics team and clinical data managers on the acquisition of feasibility results, precision patient finding lists and clinical study database development.
Read more...
She leads, directs and ensures execution of research projects in accordance with approved clinical strategy, project plans, budget and resources in compliance with applicable regulatory requirements and standard operating procedures. Tracy works proactively to identify, assess and manage clinical study risks within and across projects.
Prior to joining the CTS in 2019, Tracy was involved in both the conduct and oversight of clinical trials at the University of Wisconsin-Madison, spanning a wide array of therapeutic areas. Tracy’s experience includes the implementation of the clinical trial management software (CTMS) and REDCap electronic data capture (EDC) systems as well as clinical trial policy development, training and adherence through the conduct and oversight of the auditing and monitoring activities of investigator-initiated clinical trials.
Tracy earned her BS is Biology and Psychology from the University of Iowa and her MS in Biomedical Sciences from Barry University in Miami Shores, FL. Tracy has obtained her Project Management Professional (PMP) certification through Project Management Institute (PMI), and her Clinical Research Coordinator (CCRC) and Clinical Research Associate (CCRA) certifications through the Association of Clinical Research Professionals (ACRP).
Read Less...
Who Should Attend?
This webinar will appeal to those working in the following areas or having the following job titles:
- Director, HEOR
- Market Access
- Medical Director
- Reimbursement
- Medical Affairs
- Director of Epidemiology
- Pharmacovigilance
- HEOR
- RWD Analytics
What You Will Learn
Attendees will learn about:
- Finding eligible patients and streamlining processes for clinical trials and post-launch
- Harnessing real-world evidence (RWE) and analytics for informed decision-making
- Applying data-driven strategies for patients and providers to help optimize disease treatment and advance outcomes
Xtalks Partner
Optum Life Sciences
Optum Life Sciences, part of UnitedHealth Group’s Innovation Platform, helps connect the life sciences industry to the broader healthcare ecosystem to catalyze innovation and impact. Our experienced consultants collaborate to solve tough questions and uncover new possibilities, helping improve patient outcomes. We analyze real-world data to address the needs of payers, providers, patients and regulators. For information about our end-to-end healthcare technologies, solutions and services, including real-world evidence generation and clinical trial solutions, visit www.optum.com/life-sciences.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account